Showing results (1831-1840 of 1,951) with videos related to
Sort By:
Pageof 196
The Journal of Thoracic and Cardiovascular Surgery|April 2, 2018
Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinomaDavid B Nelson, Rajeev Dhupar, Riham Katkhuda, et al.The Annals of Thoracic Surgery|August 18, 2018
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and WomenDavid B Nelson, Danica J Lapid, Kyle G Mitchell, et al.Biorxiv : the Preprint Server for Biology|November 19, 2025
The G Protein-Coupled Receptor GPR31 Promotes Pro-inflammatory Responses in Pancreatic Islets and MacrophagesKerim B Kaylan, Christian Checkcinco, Jacob R Enriquez, et al.Nature Communications|February 15, 2024
The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylationChristopher B Nelson, Samuel Rogers, Kaushik Roychoudhury, et al.Elife|August 26, 2025
Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degenerationKaterina Rademacher, Zak Doric, Dominik Haddad, et al.Nature Communications|March 13, 2024
ZNF827 is a single-stranded DNA binding protein that regulates the ATR-CHK1 DNA damage response pathwaySile F Yang, Christopher B Nelson, Jadon K Wells, et al.Biorxiv : the Preprint Server for Biology|August 2, 2024
12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement miceTitli Nargis, Charanya Muralidharan, Jacob R Enriquez, et al.Therapeutic Advances in Infectious Disease|July 25, 2022
Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings in Davidson County, TennesseeDanielle A Rankin, Zaid Haddadin, Loren Lipworth, et al.The Journal of Thoracic and Cardiovascular Surgery|April 13, 2016
Surgical outcomes of infective endocarditis among intravenous drug usersJoon Bum Kim, Julius I Ejiofor, Maroun Yammine, et al.Arthritis and Rheumatism|July 1, 1996
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator GroupN J Olsen, R H Brooks, J J Cush, et al.Pageof 196